The global market for Substance Abuse Testing Services was valued at US$ 6718 million in the year 2024 and is projected to reach a revised size of US$ 8749 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Substance abuse testing services refer to the various diagnostic procedures and programs implemented to detect the presence of drugs or alcohol in an individual"s system. These services are employed for diverse purposes, including employment screening, legal proceedings, medical assessments, and rehabilitation programs. The primary goal is to identify and monitor substance use, helping to ensure safety, compliance, and support for individuals dealing with substance abuse issues.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Substance Abuse Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Substance Abuse Testing Services.
The Substance Abuse Testing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Substance Abuse Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Substance Abuse Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Siemens
Beckman Coulter (Danaher)
Dragerwerk
Abbott Laboratories (Alere)
F. Hoffmann-La Roche
LabCorp of America Holdings
Quest Diagnostics
Thermo Fisher Scientific
Randox Testing Services
Laboratory
Drug Testing Laboratories
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Segment by Type
Urine
Saliva
Hair
Others
Segment by Application
Hospital
Diagnostic Laboratory
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Substance Abuse Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Substance Abuse Testing Services 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Urine
1.2.3 Saliva
1.2.4 Hair
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Substance Abuse Testing Services 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Substance Abuse Testing Services 麻豆原创 Perspective (2020-2031)
2.2 Global Substance Abuse Testing Services Growth Trends by Region
2.2.1 Global Substance Abuse Testing Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Substance Abuse Testing Services Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Substance Abuse Testing Services Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Substance Abuse Testing Services 麻豆原创 Dynamics
2.3.1 Substance Abuse Testing Services Industry Trends
2.3.2 Substance Abuse Testing Services 麻豆原创 Drivers
2.3.3 Substance Abuse Testing Services 麻豆原创 Challenges
2.3.4 Substance Abuse Testing Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Substance Abuse Testing Services Players by Revenue
3.1.1 Global Top Substance Abuse Testing Services Players by Revenue (2020-2025)
3.1.2 Global Substance Abuse Testing Services Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Substance Abuse Testing Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Substance Abuse Testing Services Revenue
3.4 Global Substance Abuse Testing Services 麻豆原创 Concentration Ratio
3.4.1 Global Substance Abuse Testing Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Substance Abuse Testing Services Revenue in 2024
3.5 Global Key Players of Substance Abuse Testing Services Head office and Area Served
3.6 Global Key Players of Substance Abuse Testing Services, Product and Application
3.7 Global Key Players of Substance Abuse Testing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Substance Abuse Testing Services Breakdown Data by Type
4.1 Global Substance Abuse Testing Services Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Substance Abuse Testing Services Forecasted 麻豆原创 Size by Type (2026-2031)
5 Substance Abuse Testing Services Breakdown Data by Application
5.1 Global Substance Abuse Testing Services Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Substance Abuse Testing Services Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Substance Abuse Testing Services 麻豆原创 Size (2020-2031)
6.2 North America Substance Abuse Testing Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Substance Abuse Testing Services 麻豆原创 Size by Country (2020-2025)
6.4 North America Substance Abuse Testing Services 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Substance Abuse Testing Services 麻豆原创 Size (2020-2031)
7.2 Europe Substance Abuse Testing Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Substance Abuse Testing Services 麻豆原创 Size by Country (2020-2025)
7.4 Europe Substance Abuse Testing Services 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Substance Abuse Testing Services 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Substance Abuse Testing Services 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Substance Abuse Testing Services 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Substance Abuse Testing Services 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Substance Abuse Testing Services 麻豆原创 Size (2020-2031)
9.2 Latin America Substance Abuse Testing Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Substance Abuse Testing Services 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Substance Abuse Testing Services 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Substance Abuse Testing Services 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Substance Abuse Testing Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Substance Abuse Testing Services 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Substance Abuse Testing Services 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Details
11.1.2 Siemens Business Overview
11.1.3 Siemens Substance Abuse Testing Services Introduction
11.1.4 Siemens Revenue in Substance Abuse Testing Services Business (2020-2025)
11.1.5 Siemens Recent Development
11.2 Beckman Coulter (Danaher)
11.2.1 Beckman Coulter (Danaher) Company Details
11.2.2 Beckman Coulter (Danaher) Business Overview
11.2.3 Beckman Coulter (Danaher) Substance Abuse Testing Services Introduction
11.2.4 Beckman Coulter (Danaher) Revenue in Substance Abuse Testing Services Business (2020-2025)
11.2.5 Beckman Coulter (Danaher) Recent Development
11.3 Dragerwerk
11.3.1 Dragerwerk Company Details
11.3.2 Dragerwerk Business Overview
11.3.3 Dragerwerk Substance Abuse Testing Services Introduction
11.3.4 Dragerwerk Revenue in Substance Abuse Testing Services Business (2020-2025)
11.3.5 Dragerwerk Recent Development
11.4 Abbott Laboratories (Alere)
11.4.1 Abbott Laboratories (Alere) Company Details
11.4.2 Abbott Laboratories (Alere) Business Overview
11.4.3 Abbott Laboratories (Alere) Substance Abuse Testing Services Introduction
11.4.4 Abbott Laboratories (Alere) Revenue in Substance Abuse Testing Services Business (2020-2025)
11.4.5 Abbott Laboratories (Alere) Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Substance Abuse Testing Services Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Substance Abuse Testing Services Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 LabCorp of America Holdings
11.6.1 LabCorp of America Holdings Company Details
11.6.2 LabCorp of America Holdings Business Overview
11.6.3 LabCorp of America Holdings Substance Abuse Testing Services Introduction
11.6.4 LabCorp of America Holdings Revenue in Substance Abuse Testing Services Business (2020-2025)
11.6.5 LabCorp of America Holdings Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Substance Abuse Testing Services Introduction
11.7.4 Quest Diagnostics Revenue in Substance Abuse Testing Services Business (2020-2025)
11.7.5 Quest Diagnostics Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Substance Abuse Testing Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Substance Abuse Testing Services Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Randox Testing Services
11.9.1 Randox Testing Services Company Details
11.9.2 Randox Testing Services Business Overview
11.9.3 Randox Testing Services Substance Abuse Testing Services Introduction
11.9.4 Randox Testing Services Revenue in Substance Abuse Testing Services Business (2020-2025)
11.9.5 Randox Testing Services Recent Development
11.10 Laboratory
11.10.1 Laboratory Company Details
11.10.2 Laboratory Business Overview
11.10.3 Laboratory Substance Abuse Testing Services Introduction
11.10.4 Laboratory Revenue in Substance Abuse Testing Services Business (2020-2025)
11.10.5 Laboratory Recent Development
11.11 Drug Testing Laboratories
11.11.1 Drug Testing Laboratories Company Details
11.11.2 Drug Testing Laboratories Business Overview
11.11.3 Drug Testing Laboratories Substance Abuse Testing Services Introduction
11.11.4 Drug Testing Laboratories Revenue in Substance Abuse Testing Services Business (2020-2025)
11.11.5 Drug Testing Laboratories Recent Development
11.12 Biomedical Diagnostics
11.12.1 Biomedical Diagnostics Company Details
11.12.2 Biomedical Diagnostics Business Overview
11.12.3 Biomedical Diagnostics Substance Abuse Testing Services Introduction
11.12.4 Biomedical Diagnostics Revenue in Substance Abuse Testing Services Business (2020-2025)
11.12.5 Biomedical Diagnostics Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Details
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Substance Abuse Testing Services Introduction
11.13.4 BioMerieux Revenue in Substance Abuse Testing Services Business (2020-2025)
11.13.5 BioMerieux Recent Development
11.14 Bio-Rad
11.14.1 Bio-Rad Company Details
11.14.2 Bio-Rad Business Overview
11.14.3 Bio-Rad Substance Abuse Testing Services Introduction
11.14.4 Bio-Rad Revenue in Substance Abuse Testing Services Business (2020-2025)
11.14.5 Bio-Rad Recent Development
11.15 Dako
11.15.1 Dako Company Details
11.15.2 Dako Business Overview
11.15.3 Dako Substance Abuse Testing Services Introduction
11.15.4 Dako Revenue in Substance Abuse Testing Services Business (2020-2025)
11.15.5 Dako Recent Development
11.16 DiaSorin
11.16.1 DiaSorin Company Details
11.16.2 DiaSorin Business Overview
11.16.3 DiaSorin Substance Abuse Testing Services Introduction
11.16.4 DiaSorin Revenue in Substance Abuse Testing Services Business (2020-2025)
11.16.5 DiaSorin Recent Development
11.17 Eiken
11.17.1 Eiken Company Details
11.17.2 Eiken Business Overview
11.17.3 Eiken Substance Abuse Testing Services Introduction
11.17.4 Eiken Revenue in Substance Abuse Testing Services Business (2020-2025)
11.17.5 Eiken Recent Development
11.18 Fujirebio
11.18.1 Fujirebio Company Details
11.18.2 Fujirebio Business Overview
11.18.3 Fujirebio Substance Abuse Testing Services Introduction
11.18.4 Fujirebio Revenue in Substance Abuse Testing Services Business (2020-2025)
11.18.5 Fujirebio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Siemens
Beckman Coulter (Danaher)
Dragerwerk
Abbott Laboratories (Alere)
F. Hoffmann-La Roche
LabCorp of America Holdings
Quest Diagnostics
Thermo Fisher Scientific
Randox Testing Services
Laboratory
Drug Testing Laboratories
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
听
听
*If Applicable.
